AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Alex F Herrera

Alex F Herrera

Beckman Research Institute of City of Hope - California / United States
Others
AD Scientific Index ID: 4607402
City of Hope National Medical Center
person_outline Alex F Herrera's MOST POPULAR ARTICLES
1-) Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial The lancet oncology 20 (1), 31-42, 2019
2-) Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma Journal of Clinical Oncology 38 (2), 155-165, 2020
3-) Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma Blood, The Journal of the American Society of Hematology 131 (11), 1183-1194, 2018
4-) Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma Blood, The Journal of the American Society of Hematology 141 (19), 2307-2315, 2023
5-) Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity Journal of Clinical Oncology 38 (27), 3095-3106, 2020